ALDX · Aldeyra Therapeutics, Inc.

0001193125-26-164198

Summary

Martin J. Joyce, a member of Aldeyra Therapeutics' Board of Directors, notified the company on April 20, 2026, of his decision not to stand for re-election at the 2026 annual meeting and will serve until his term expires.

Key takeaways

Martin J. Joyce notified Aldeyra of his decision not to stand for re-election at the 2026 Annual Meeting.
Mr. Joyce will continue serving on the Board until his term expires at the 2026 Annual Meeting.
The decision was not due to any disagreement with Aldeyra.
No successor has been named in the filing.

Full analysis

Martin J. Joyce's decision to not seek re-election at the 2026 Annual Meeting represents a planned board transition without any disclosed conflicts or issues with company management or strategy. He will remain in his role through the meeting, ensuring continuity. Investors should monitor upcoming proxy materials for details on board composition and any planned appointments to maintain governance stability.